PFE vs WFC: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and Wells Fargo & Company โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-05.
Pfizer Inc. ยท Healthcare
$26.33
+28.6% upside to fair value
Grade B
VS
Wells Fargo & Company ยท Financial Services
$81.52
+30.6% upside to fair value
Grade B
QuantHub Verdict
WFC has more upside to fair value (+30.6%). WFC trades at a lower forward P/E (11.9x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric PFE WFC
Current Price $26.33 $81.52
Fair Value Estimate $33.85 $106.48
Upside to Fair Value +28.6% +30.6%
Market Cap $149.8B $250.7B
Forward P/E 19.3x 11.9x
EV / EBITDA 12.9x 16.7x
Price / Sales 2.4x 2.0x
Price / FCF 16.5x -13.2x
Revenue Growth YoY -1.2% +7.3%
Gross Margin 70.3% 64.5%
Operating Margin 24.7% 20.5%
Return on Equity 8.7% 12.0%
Dividend Yield 0% 0%
FCF Yield 6.06% โ€”
Analyst Consensus Hold Buy
Investment Thesis
PFE โ€” Pfizer Inc.
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating maโ€ฆ
WFC โ€” Wells Fargo & Company
Wells Fargo & Company is a diversified financial services firm operating primarily in consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. The company benefits from a seasoned CEO with extensive industry experience and has made significant progress in regulatory compliance and operational efficiency, including lifting its asset cap in 2025.โ€ฆ
Accumulation Zones
Metric PFE WFC
Zone Low $25.39 $79.86
Zone High $28.77 $90.51
In Buy Zone? Yes Yes
โ† PFE Research    WFC Research โ†’    All Research